These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8192286)
21. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
22. [Prevalence of hepatitis B and C among prison population in Croatia]. Burek V; Horvat J; Susić E; Mikulić R Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906 [TBL] [Abstract][Full Text] [Related]
23. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico]. Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281 [TBL] [Abstract][Full Text] [Related]
24. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. Tripathi AK; Khanna M; Gupta N; Chandra M J Assoc Physicians India; 2007 Jun; 55():429-31. PubMed ID: 17879496 [TBL] [Abstract][Full Text] [Related]
25. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252 [TBL] [Abstract][Full Text] [Related]
27. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555 [TBL] [Abstract][Full Text] [Related]
28. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797 [TBL] [Abstract][Full Text] [Related]
29. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340 [TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078 [TBL] [Abstract][Full Text] [Related]
32. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C; J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966 [TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808 [TBL] [Abstract][Full Text] [Related]
34. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)]. Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493 [TBL] [Abstract][Full Text] [Related]
35. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888 [TBL] [Abstract][Full Text] [Related]
36. [High prevalence of infection by hepatitis B virus and HIV in incarcerated French drug addicts]. Espinoza P; Bouchard I; Buffet C; Thiers V; Pillot J; Etienne JP Gastroenterol Clin Biol; 1987 Apr; 11(4):288-92. PubMed ID: 3582884 [TBL] [Abstract][Full Text] [Related]
37. [Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene--a prevalence study]. Röhrig S; Grob PJ Schweiz Med Wochenschr; 1990 Apr; 120(17):621-9. PubMed ID: 2160123 [TBL] [Abstract][Full Text] [Related]
38. [A survey on HIV and HV infection of heroin addicts in Linchang and Kunming]. Tang B; Tong L; Yan Q Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Jul; 29(4):228-30. PubMed ID: 7587665 [TBL] [Abstract][Full Text] [Related]
39. Seroprevalence of HBV and HCV markers among intravenous drug abusers and subjects affected by chronic active hepatitis. De Mercato R; Ciampi R; Romano A; Guarnaccia D; Siciliano V; Cantiello JP; Rippa O; Celentano U; Selva V; Romano C Boll Soc Ital Biol Sper; 1990 Sep; 66(9):841-7. PubMed ID: 2127365 [TBL] [Abstract][Full Text] [Related]
40. [Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89]. Kielland KB; Siebke JC Tidsskr Nor Laegeforen; 1991 Mar; 111(7):821-4. PubMed ID: 1902331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]